We are switching to a unified release naming system for all of our products, based on the calendar year.
The year-based nomenclature makes sense as LORENZ products become more and more integrated – acting as interlocking components in a single Regulatory Information Management suite. The new naming convention also follows best practice in the industry, and will help increase clarity on which version of each product is the most current – especially for customers who are using two or more LORENZ solutions in integrated environments.
For a detailed explanation of the new naming system, please click here.
To stay informed about both major and minor releases, please subscribe to Product & Service Update Announcements in your LORENZ ID.
We would like to provide our customers and the industry with an update on the status of LORENZ’ implementation of LORENZ docuBridge, eValidator, and Automator at the U.S. Food and Drug Administration (FDA).
(Please click here to read our previous blogpost including a timeline of events from 1 July 2016 – 30 May 2017.)
Read the full article here:
Today Jared Lantzy, Manager Global Regulatory Agencies and Processes at LORENZ, starts with a series of articles talking about international trends in Drug Registration and Evaluation. He will provide an update on some selected topics in electronic submissions and some insight into how LORENZ will deal with these evolving regulatory requirements.
Regulatory authorities around the world continue to adopt internationally recognized data standards in an effort to improve the efficiency of their work environments and processes. The most commonly discussed data standards are the Electronic Common Technical Document (eCTD); International Organization for Standardization (ISO) Identification of Medicinal Products (IDMP); Health Level 7 (HL7) Structured Product Labeling (SPL)-based standards for the transmission of product data, including IDMP; and Clinical Data Interchange Standards Consortium (CDISC)-based standards for both clinical and non-clinical study data.
We at LORENZ have been receiving an increasing number of emails and phone calls from our customers and partners concerning the current state of the project implementing LORENZ docuBridge, eValidator, and Automator at the U.S. Food and Drug Administration (FDA).
In order to clarify the chain of events and alleviate any concerns, we are outlining below a timeline of events we hope will be helpful.
Do you want to learn more about LORENZ Solutions @ Customers? Read about how LORENZ docuBridge enables a leading pharmaceutical company to deliver compliant drug dossiers to agencies around the globe.
Do you want to learn more about LORENZ Solutions @ Customers? In this video Giacomo Ridi of Menarini Ricerche S.p.A. talks about LORENZ Solutions at the Menarini Group and provides his insights on the work prior to using LORENZ solutions, the challenges in implementing the LORENZ solutions and the improvements achieved together with LORENZ.